Multiplex assay combines non-invasive biosensor measurement with live cell imaging SANTA CLARA, Calif.–Agilent Technologies Inc. (NYSE: A) today introduced a multimode real-time cell analyzer (RTCA)—the first of its kind—combining the best of non-invasive biosensor measurement with live cell imaging. “The xCELLigence RTCA eSight will revolutionize cell analysis in life science research,” said Todd Christian, Agilent vice president, and […]

Mystic, CT and Ipswich, MA: Reforest The Tropics (RTT), a 501(c)(3) non-profit organization based in Mystic, Connecticut and New England Biolabs, Inc. (NEB®), a global leader in the production of reagents for the life science industry, announce that they have entered into an agreement to plant 100 hectares (247 acres) of new tropical forest in Costa […]

Carterra® Opens a Customer Experience Center in Munich; Adds European Sales, Support, and Service Team SALT LAKE CITY, UTAH, USA AND MARTINSRIED/PLANEGG, MUNICH, GERMANY – Carterra® Inc., the world leader in high-throughput antibody screening and characterization, announced today that they have opened a Customer Experience Center (CEC) and office in Munich, Germany. Rapid European adoption of […]

MINNEAPOLIS and SOUTHPORT, N.C. — Bio-Techne Corporation and Cygnus Technologies, part of Maravai LifeSciences, announced today a strategic partnership for the quantification of Chinese hamster ovary host cell proteins (CHO-HCP) on the ProteinSimple™-branded Ella™ immunoassay platform. Under the terms of the agreement, Bio-Techne and Cygnus are introducing the co-developed third generation CHO-HCP assay in the […]

New Hi-C Kit Offers a Powerful New Tool to Help Researchers Expand Their Understanding of Genome Structure, Generate High Quality Genome Assemblies and Detect Genetic Variants SCOTTS VALLEY, Calif. — Dovetail Genomics, the industry leader in advanced genomic solutions for proximity ligation, today announced the global availability of its latest Hi-C offering, Omni-C. The new kit offers […]

The alliance will leverage Mission Bio’s Tapestri Platform to investigate Onconova’s novel cancer therapy rigosertib, through clinical trials NEWTOWN, Pa. and SOUTH SAN FRANCISCO, Calif., August 12, 2019 — Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company discovering and developing novel products to treat cancer, with a focus on Myelodysplastic Syndromes (MDS), […]

ForteBio, the Biologics Business Unit of Molecular Devices, announced today at Bioprocessing Summit in Boston, the release of the new High Precision Streptavidin 2.0 (SAX2) biosensor for the Octet® platform. Focused on meeting customers’ needs to minimize variability from consumables, the SAX2 biosensors are controlled to meet the most stringent of assay precision requirements with […]

908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, today announced the launch of their new bioprocess analyzer, the Rebel™. This first-of-its-kind, miniature CE-MS-based analyzer lets biopharma researchers accelerate process development cycles and maximize their bioreactor utilization by running media analysis at-line, anytime. The company is presenting the Rebel for the first […]

Biognosys closes Series G round with new and existing investors to accelerate implementation of discovery proteomics in clinical trials.  SCHLIEREN, (Zurich, Switzerland). Biognosys, a Swiss proteomics company, continues realizing its ambition to enable clinical researchers to directly measure and quantify thousands of proteins from patient tissues in clinical trials by offering its next-generation label-free proteomics technology. […]

Bournemouth, UK: Solentim, the innovator and World leader in Cell Line Development instrumentation, is pleased to announce that it achieved very strong revenue growth and financial results for the first half of 2019. Commenting on the performance, Dr Ian Taylor, Chief Commercial Officer noted “Our results are in line with the current surge in the bioprocessing […]